Clinical Trial Update: Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan) [Phase 2]

View source ↗

Summary

Phase 2 study results report safety and immunogenicity of an AIDS vaccine using a DNA vaccine in combination with recombinant vaccinia Tiantan; the trial has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome

Drugs mentioned

• AIDS DNA vaccine (DNA vaccine)
• Recombinant vaccinia Tiantan (recombinant vaccinia Tiantan)

Snippet

Sponsor: National Center for AIDS/STD Control and Prevention, China CDC | Conditions: AIDS | Phase 2 | Status: COMPLETED